Study Comparing the Safety and Efficacy of Piperacillin/Tazobactam to Cefepime in Patients With Hematologic Malignancy or Lymphoma

NCT00044759 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Hematologic Neoplasms

Interventions

DRUG: Piperacillin/Tazobactam (Tazocin)

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer